Anúncio
Anúncio

TWST

TWST logo

Twist Bioscience Corporation Common Stock

35.34
USD
Patrocinado
+0.60
+1.73%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

35.50

+0.16
+0.45%

Relatórios de Lucros TWST

Rácio de surpresa positiva

TWST separação 18 de 29 últimas estimativas.

62%

Próximo Relatório

Data do Próximo Relatório
30 de jan. de 2026
Estimate for Q1 26 (Revenue/ EPS)
$102.37M
/
-$0.44
Mudanças implicadas de Q4 25 (Revenue/ EPS)
+3.39%
/
-2.22%
Mudanças implicadas de Q1 25 (Revenue/ EPS)
+15.39%
/
-16.98%

Twist Bioscience Corporation Common Stock earnings per share and revenue

On 14 de nov. de 2025, TWST reported earnings of -0.45 USD per share (EPS) for Q4 25, missing the estimate of -0.43 USD, resulting in a -2.79% surprise. Revenue reached 99.01 milhão, compared to an expected 99.26 milhão, with a -0.26% difference. The market reacted with a -10.13% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analistas forecast an EPS of -0.44 USD, with revenue projected to reach 102.37 milhão USD, implying an diminuir of -2.22% EPS, and aumentar of 3.39% in Revenue from the last quarter.
FAQ
For Q4 2025, Twist Bioscience Corporation Common Stock reported EPS of -$0.45, missing estimates by -2.79%, and revenue of $99.01M, -0.26% below expectations.
The stock price moved down -10.13%, changed from $29.90 before the earnings release to $26.87 the day after.
The next earning report is scheduled for 30 de jan. de 2026.
Based on 11 analistas, Twist Bioscience Corporation Common Stock is expected to report EPS of -$0.44 and revenue of $102.37M for Q1 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio